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b Department of Regenerative Pharmacology, Research Center Kobe, Bayer Yakuhin Ltd., Kobe, Hyogo 650-0047, JapanReceived 21 December 2007; received in revised form 9 January 2008; accepted 12 January 2008Abstract Induction of pluripotent stem cells from human fibroblasts has been achieved by the ectopic expression of two different
sets of four genes. However, the mechanism of the pluripotent stem cell induction has not been elucidated. Here we identified
a marked heterogeneity in colonies generated by the four-gene (Oct3/4, Sox2, c-Myc, and Klf4) transduction method in human
neonatal skin-derived cells. The four-gene transduction gave a higher probability of induction for archetypal pluripotent stem
cell marker genes (Nanog, TDGF, and Dnmt3b) than for marker genes that are less specific for pluripotent stem cells (CYP26A1
and TERT) in primary induction culture. This tendency may reflect the molecular mechanism underlying the induction of
human skin-derived cells into pluripotent stem cells. Among the colonies induced by the four-gene transduction, small cells with a
high nucleus-to–cytoplasm ratio could be established by repeated cloning. Subsequently established cell lines were similar to
human embryonic stem cells as well as human induced pluripotent stem (iPS) cells derived from adult tissue in morphology, gene
expression, long-term self-renewal ability, and teratoma formation.Genome-wide single-nucleotidepolymorphismarray analysis of
the human iPS cell line indicates that the induction process did not induce DNA mutation.
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doi:10.1016/j.scr.2008.01.001the former being embryonic stem cells and the latter em-
bryonic germ cells (Shamblott et al., 1998; Thomson et al.,
1998). If pluripotent stem cells could be generated from
postnatal tissue of an individual patient, these would greatly
facilitate the therapeutic application of stem cells by
avoiding the immune rejection by the recipient which is
associated with allograft transplants (Hochedlinger and
Jaenisch, 2003; Yang et al., 2007). They would also have
the potential to be used in patient-specific in vitro models
for studying disease etiology and the role of genetic variation
in response to drugs. Somatic cell nuclear transfer and fusion
of somatic cells with ES cells have been used for this purpose,.
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(Cowan et al., 2005; Hochedlinger and Jaenisch, 2006;
Tada et al., 2001; Yamanaka, 2007). It was shown that
ectopic expression of four transcription factors, Oct3/4
(POU5F1), Sox2, c-Myc, and Klf4, in mouse fibroblasts
induces pluripotent stem cells (Blelloch et al., 2007;
Maherali, 2007; Meissner et al., 2007; Okita et al., 2007;
Takahashi and Yamanaka, 2006; Wernig et al., 2007). Germ-
line-competent pluripotent stem cells generated from
mouse fibroblasts by the four-gene transduction method
were isolated by using Nanog or Oct3/4 as a selection factor
(Maherali, 2007; Okita et al., 2007; Wernig et al., 2007).
Recently, itwas shown that two different sets of four genes can
induce pluripotent stem cells from human fibroblasts (Takaha-
shi et al., 2007; Yu et al., 2007). In addition, it was suggested
that c-Myc is not necessary for the induction of human induced
pluripotent stem (iPS) cells (Nakagawa et al., 2007). However,
the mechanism underlying pluripotent stem cell induction has
not been elucidated.
Here we used a method for the transduction of human
neonatal skin-derived cells that employs adenovirus carrying
the ecotropic receptor mCAT1 followed by Moloney murine
leukemia virus (MMLV)-derived vectors carrying the four
transcription factors Oct3/4, Sox2, c-Myc, and Klf4 (Koch et
al., 2006).Using thismethod, human skin fibroblasts gave rise to
colonies expressing alkaline phosphatase (ALP) and Nanog
17 days after the four-gene transduction. However, ALP/
Nanog double-positive cells were heterogeneous and included
cells lacking expression of one or more of the TDGF1, Dnmt3b,
Zfp42, FoxD3, GDF3, CYP26A1, and TERT genes. The four-gene
transduction gave a higher probability of induction for arche-
typal pluripotent stem cell marker genes (Nanog, TDGF1, and
Dnmt3b) than for marker genes that are less specific for
pluripotent stem cells (CYP26A1 and TERT). This tendency may
reflect the molecular mechanism underlying the induction of
human skin-derived cells into pluripotent stem cells. Among the
colonies induced by the four-gene transduction, small cells with
a high nucleus-to-cytoplasm ratio could be established by
repeated cloning. Subsequently established cell lines were
similar to human embryonic stem cells in morphology, gene
expression, long-term self-renewal ability, and teratoma for-
mation. The four transgenes that were used to induce the
pluripotent cells were found to be silenced in the established
pluripotent cell clones. We also investigated the DNA mutation
ratio associated with the process of pluripotent stem cell
induction. Genome-wide single-nucleotide polymorphism array
analysis was performed for the human iPS clone 1–8 and its
parental cell, and no marked differences were observed.
Consistent with these observations, the HLA genotype of the
human iPS clone and the parental cells was identical. These
results indicate that the induction processes do not introduce
DNA mutations.
Results
Analysis of colonies induced by ectopic expression
of the four genes in human skin-derived cells
Human neonatal skin-derived cells were infected with an
adenovirus vector carrying the murine retrovirus receptor
mCAT. Subsequently, the cells were exposed to replication-deficient MMLV-derived vectors carrying human Oct3/4,
Sox2, c-Myc, and Klf4 cDNA. The cells were fixed and stained
for ALP on day 17 after the four-gene transduction, when the
cells had become fully confluent. In total, 163 ALP-positive
colonies and 80–90 ALP-negative colonies were observed in
four independent experiments. All 163 ALP-positive colonies
and 18 ALP-negative colonies were isolated for gene expres-
sion analysis using real-time polymerase chain reaction with
reverse transcription. Eight genes (Nanog, TDGF1, Dnmt3b,
Zfp42, FoxD3, GDF3, CYP26A1, and TERT) that are reported
to be expressed in human ES cells were selected as plu-
ripotent stem cell marker genes (Adewumi et al., 2007;
Assou et al., 2007). Human neonatal skin fibroblasts did not
express any of these eight genes. Gene expression profiles of
163 ALP-positive colonies and 18 ALP-negative colonies were
categorized according to the number of genes expressed
from the panel of these eight ES cell markers and are shown
in Table 1. Four of 163 ALP-positive colonies were positive for
all eight markers (Table 1). The efficiency of inducing these
octa-positive colonies was 0.0005–0.0015% of the initial
parent cell count (Fig. 1A).
Nanog gene expression was observed in 161 of 163 ALP-
positive colonies and 16 of 18 ALP-negative colonies (Table 1).
The pluripotent stem-cell-like colonies (Figs. 1C–1J) as well as
fibroblastic colonies (Figs. 1K–1N)expressedNanog.On theother
hand, expression of CYP26A1 and TERT was observed in only
26 and 24 of 163 ALP-positive colonies respectively (Fig. 1B,
Table 1). Approximately 90% of TERT-positive cells expressed
more than six of the eight ES cell marker genes. Genes such as
Nanog, TDGF1, and Dnmt3b, which are well known to be closely
associated with the pluripotent state in human ES cells and to be
strongly down regulated upon their differentiation, had a high
probability of induction by the four-gene transduction. These
archetypal pluripotent stemcellmarker genes (Nanog,TDGF, and
Dnmt3b) were expressed not only in stem-cell-like colonies but
also in fibroblastic colonies (Figs. 1K–1N).
ALP-positive colonies could be categorized into 40 groups
based on the gene expression pattern of the eight marker
genes (Table 1). When colonies were categorized by the total
number of the eight marker genes expressed, a binomial
distribution was obtained, suggesting that there is a stochastic
process in colony induction in addition to the gene selective
mechanism (Fig. 1A).
Although the four transgenes were clearly silenced in the
iPS clones 94 days after the four-gene transduction (Supple-
mentary Fig. 1K), quantitative gene expression analysis of
colonies formed 17 days after infection indicated that the
transgenes c-Myc and Oct3/4 showed high expression in all the
analyzed colonies (Supplementary Table 1). In addition,
endogenous Nanog expression was very high in most of the
ALP-positive colonies, including cells lacking expression of one
or more of the eight human ES cell marker genes (Supplemen-
tary Table 1). These results indicate that the process of
pluripotent stem cell induction from human skin-derived cells
is slower than that described for mouse iPS cell generation
(Maherali, 2007; Okita et al., 2007; Wernig et al., 2007).
Isolation and establishment of human induced
pluripotent stem cell lines
Cells of the four octa-positive (Nanog, TDGF1, Dnmt3b, Zfp42,
FoxD3, GDF3, CYP26A1, and TERT) colonies showed common
Table 1 Gene expression profiles of ALP(+) and ALP(−) colonies
No. No. of genes Nanog TDGF1 Dnmt3b Zfp42 FoxD3 GDF3 CYP26A1 TERT No. of colonies
Gene expression patterns in ALP(+) colonies
1 8 + + + + + + + + 4
2 7 + + + + + + + − 7
3 7 + + + + + + − + 11
4 7 + + + + + − + + 1
5 6 + + + + + + − − 25
6 6 + + + + + − + − 4
7 6 + + + + + − − + 3
8 6 + + + + − + − + 2
9 6 + + + + − + + − 3
10 6 + + + − + + + − 1
11 6 + + + − − + + + 1
12 5 + + + + + − − − 22
13 5 + + + + − + − − 9
14 5 + + + + − − + − 2
15 5 + + + − + + − − 4
16 5 + + + − + − + − 2
17 5 + + + − − + + − 1
18 5 + + − + + + − − 2
19 5 + + − + + − − + 1
20 4 + + + + − − − − 9
21 4 + + + − + − − − 3
22 4 + + + − − + − − 5
23 4 + + − + + − − − 7
24 4 + − + + + − − − 1
25 4 + − + − + + − − 2
26 4 + − − + + + − − 1
27 3 + + + − − − − − 1
28 3 + + − + − − − − 3
29 3 + + − − + − − − 4
30 3 + + − − − − − + 1
31 3 + − + + − − − − 1
32 3 + − + − + − − − 2
33 3 + − + − − + − − 1
34 3 + − − + + − − − 1
35 3 + − − − + + − − 1
36 2 + + − − − − − − 4
37 2 + − + − − − − − 5
38 2 + − − + − − − − 2
39 1 + − − − − − − − 2
40 0 − − − − − − − − 2
Gene expression patterns in ALP(−) colonies
41 6 + + + + + − + − 1
42 6 + + − + + + − + 1
43 5 + + + + + − − − 3
44 5 + + − + + − − + 6
45 4 + + + − + − − − 1
46 4 + + − + + − − − 1
47 4 + + + − − − − + 1
48 2 + − − − − − − + 1
49 1 + − − − − − − − 1
50 1 − + − − − − − − 1
51 0 − − − − − − − − 1
107Heterogeneity of pluripotent marker gene expression in colonies generated in human iPS cell induction culturefeatures that are consistent with the features of human ES
cells: (1) small size with a high nucleus-to-cytoplasm ratio and
(2) formation of small monolayer colonies within the spacebetween fibroblasts (Figs. 1C–1F and 2B). Based on these
common features, colonies were isolated without ALP staining
at 17 to 33 days after four-gene transduction (Fig. 2B).
Figure 1 Human ES cell marker gene expression profile in ALP-positive colonies. Colonies were stained for alkaline phosphatase
17 days after four-gene transfer. All ALP+colonies were dissected and their human ES cell marker gene expression was determined.
(A) The graph shows the distribution of colonies induced in four independent experiments based on the number of human ES cell
marker genes expressed. 2×104 cells were infected in Experiments 1 and 3, and 2×105 cells were infected in Experiments 2 and 4. (B)
The number of colonies expressing Nanog, TDGF1, Dnmt3b, Zfp42, FoxD3, GDF3, CYP26A1, and TERT genes. (C–N) Morphology of
human ES-cell-like colonies that expressed all eight of the ES cell marker genes (C–F) or that lack two (G, H) or three (I, J) of the eight
marker genes are shown after fixation and staining for ALP. The morphology of fibroblastic colonies that did not express TERTand GDF3
(K, L) or TERT, CYP26A1, and GDF3 (M, N) is also shown. Scale bar, 500 μm.
108 H. Masaki et al.Approximately half of the colonies isolated by morphological
criteria stopped proliferating or changed their morphology
during subcloning. Indeed our fixed-colony analysis indicated
that someof the ES cell-like colonies thatwere revealed by the
high-density ALP staining in Figs. 1G–1J lack one ormore of the
eight marker genes.
Three human ES-like cell lines, which we termed human iPS
clones 1–8, 2–4, and 3–2, were established by repeated
cloning. They were morphologically indistinguishable from
typical human ES cells, consisting of small, round cells with ahighnucleus-to-cytoplasm ratio anddefinededges (Figs. 2C–F).
All established lines expressed the eight ES cell marker genes
used for the analyses of primary induction cultures (Supple-
mentary Table 2). Efficiency of establishing the human iPS cell
lines was about 0.001–0.01% of the initial parent cells, which is
consistent with the efficiency of octa-positive colony forma-
tion. All three clones could be cultured onmitomycin C-treated
mouse embryonic fibroblast (MEF) feeder layers as well as
under feeder-free conditions in mTeSR1 defined medium.
Treatment with the Rho-associated protein kinase inhibitor
Figure 2 Induction and expansion of pluripotent stem cells. (A, B) Morphology of the parental cells (A) and a colony in primary
induction culture, which was later established as human iPS clone 3–2 (B). (C–F) Representative morphology of clone 1–8 cultured on
MEF feeder cells (C), and clones 1–8, 2–4, and 3–2 cultured in mTeSR1 medium (D–F). Scale bar indicates 200 μm. (G) Growth record of
clone 1–8. The square indicates the period over which cell numbers were counted to estimate cell proliferation rate. (H) Multicolor
karyogram image. Karyotype was normal at day 101.
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(Watanabe et al., 2007). Human iPS clone1-8 has been
expanded over more than 33 passages, which corresponds to
190 days in culture after the four-gene infection (Fig. 2G).
The population doubling time of human iPS clone 1–8 in
feeder-free mTeSR culture medium was approximately 48.5 h
when analyzed between passages 19 and 26 (Fig. 2G). Multi-
color FISH analysis showed no chromosomal translocation or
deletion (Fig. 2H). These results indicate that the induction
procedure does not generate chromosomal abnormalities. The
human iPS clone 1–8 was positive for ALP as well as the
carbohydrate antigens SSEA-3 and SSEA-4, the keratin sulfateantigens TRA-1–60 and TRA-1–81, and the protein antigens
CD9, CD24, and Thy1 (Supplementary Figs. 1A–I). They also
expressed the human ES cell marker genes Nanog, Oct3/4,
Sox2, TDGF1, Dnmt3b, GABRB3, GDF3, TERT, Sall4, Zfp42, and
CYP26A1 (Supplementary Figs. 1J and K). The four exogenous
transcription factor genes, were silenced in cells from human
iPS clone 1–8 at day 94 (Supplementary Fig. 1K).
Global gene expression in human iPS cell lines
The global gene expression profiles of the human iPS lines (1–
8, 2–4, and 3–2) and their parental fibroblasts were analyzed
Figure 3 Hierarchical cluster analysis. Two-way cluster analysis was performed for the genes defined by the International Stem Cell
Initiative (except for PTF1A). Human iPS clone 1–8 cultured in mTeSR (1–8mTeSR), clone 1–8 cultured in mTeSR after freeze–thaw
treatment (1–8 mTeSR(f&t)), clone 1–8 cultured in MEF-conditioned medium (1–8CM), clone 1–8 cultured on MEF (1–8MEF), clone 2–4
cultured in mTeSR (2–4mTeSR), clone 2–4 cultured on MEF (2–4MEF), clone 3–2 cultured in mTeSR (3–2mTeSR), their parental cells
(5F0438 and 5F0416), human ES cell line Sheff 4 cultured on MEF (hES1, hES2, hES3), human ES cell line Sheff 4 cultured on Matrigel
(hES4, hES5), human ES cell line H14 cultured on MEF (hES6, hES7), and fibroblast data from the GEO database (Fibroblasts1, 2, and 3)
were used for the analysis. Expression intensity ranges from red (high) to green (low).
110 H. Masaki et al.using microarray technology. Hierarchical cluster analysis
using the gene set defined by the International Stem Cell
Initiative (Supplementary Table 6) (Adewumi et al., 2007)
revealed that the human iPS lines (1–8, 2–4, and 3–2)
clustered with human ES cell lines but separated from their
parental skin-derived cells (Fig. 3). This analysis indicates that
the difference between the human iPS cell lines and an
established human ES cell line (H14) are smaller than the
differences among established ES cell lines. Representative
scatter plots indicated that the human ES cell marker genes,
Nanog, Oct3/4, TDGF1, Dnmt3b, GABRB3, GDF3, Zfp42, and
ALP, showeda high correlation betweenhuman iPS cell line 1–8
and human ES cell line H14 (Supplementary Fig. 2A). In
contrast, these genes did not correlate between the human iPS
cell line 1–8 and its parental cells (Supplementary Fig. 2B).
The human iPS cell lines (1–8, 2–4, and 3–2) established from
neonatal skin-derived cells in this study were similar in terms
of global gene expression to a human iPS cell line (201B)
established from adult fibroblasts (Table 2).Table 2 Pearson correlation coefficients between human iPS cel
hiPS 1–8mTeSR hiPS 2–4mTeSR h
hiPS 2–4mTeSR (neonate) 0.959
hiPS 3–2mTeSR (neonate) 0.935 0.919
hiPS 201B (adult) 0.868 0.845 0
hES H9 (embryo) 0.915 0.896 0
hES ES01(embryo) 0.923 0.902 0
hES BG03 (embryo) 0.939 0.923 0
Fibroblasts (adult) 0.516 0.515 0DNA methylation of human iPS cell lines
To investigate the DNAmethylation status of Nanog andOct3/4
promoter regions of human iPS cell lines 1–8 and 2–4, bisulfite
genomic DNA fragments were analyzed using MALDI-TOF MS.
The Oct3/4 proximal promoter including conserved region 1
(CR1), theOct3/4 promoter distal enhancer including CR4, and
the Nanog proximal promoter including Oct3/4 and Sox2
binding sites were examined (Fig. 4A) (Rodda et al., 2005; Yang
et al., 2005). As shown in Fig. 4B, cytosine–phosphate–
guanosine (CpG) dinucleotides in these regions were demethy-
lated in human iPS cell lines 1–8 and 2–4 compared to their
parental cells.
Pluripotency of the human iPS cell line
Human iPS clone 1–8 gave rise to teratomas 4 to 8 weeks after
transplantation into the testis of SCID mice. The teratomas
contained tissues representative of all three germ layers,l lines from adult or neonate and human ES cell lines
iPS 3–2mTeSR hiPS 201B hES H9 hES ES01 hES BG03
.908
.889 0.902
.897 0.906 0.982
.913 0.885 0.974 0.975
.561 0.621 0.525 0.530 0.509
Figure 4 Methylation pattern of Nanog and Oct3/4 promoter regions. (A) Parts of the Oct3/4 promoter including the distal enhancer
(Oct3/4-Z1) and the proximal promoter region (Oct3/4-Z2) and parts of the Nanog promoter including the proximal promoter region
(Nanog-Z1,-Z2) were analyzed for methylation of CpG. (B) All of the CpG sites in the promoter region defined in (A) are indicated by
the circles from 5′ (left) to 3′; (right).
111Heterogeneity of pluripotent marker gene expression in colonies generated in human iPS cell induction cultureneuroectoderm, mesoderm, and endoderm. Immunohistologi-
cal analyses revealed that neural epithelium, cartilage, smooth
muscle, and endodermal tract were formed as multiple tissues
from each germ layer, demonstrating the pluripotency of
human iPS clone 1–8 (Fig. 5, Supplementary Fig. 3). Pluripo-
tency was maintained after freeze–thaw treatment of human
iPS clone 1–8 (Supplementary Figs. 3T–F1 and 3T–F2).
Genotyping of the human iPS cell lines
Southern blot and genomic-PCR analysis indicated that
human iPS clone 1–8 carries ectopically transduced Oct3/
4, Sox2, c-Myc, and Klf4 genes in the genome (Supplemen-
tary Fig. 4), suggesting that the two-step infection procedure
was effective. The other two clones also carried the four
transgenes (data not shown).To investigate the DNA mutation ratio associated with the
process of pluripotent stemcell induction, genome-wide single-
nucleotide polymorphism array analysis was performed for
human iPS clone 1–8 (n=2), its parental skin-derived cells
(n=2), and skin cells derived from another donor (n=1). No
markeddifferenceswereobservedbetweenhuman iPS clone1–
8 and the parental cells (Table 3). Consistent with these
observations, HLA genotypes of human iPS cell lines 1–8, 2–4,
and 3–2 were identical to those of their respective parental
cells (Supplementary Table 3).
Discussion
Our results demonstrate that introduction of four transcription
factors, Oct3/4, Sox2, c-Myc, and Klf4, is sufficient to induce
Table 3 Consistent SNP (%) between human iPS clone1–8,
its parental skin-derived cells (5F0438), and skin cells
derived from a different donor (5F0416)
iPS 1–8_01 iPS 1–8_02 5F0438_01 5F0438_02
iPS 1–8_02 99.41
5F0438_01 99.17 99.26
5F0438_02 99.44 99.44 99.32
5F0416 60.50 60.75 60.72 60.47
112 H. Masaki et al.human ES-cell-like pluripotent stem cells from cells obtained
from neonatal human skin tissues, indicating that neonatal-
derived tissues as well as adult-derived tissues have the
competence to generate iPS cells. The induced pluripotent
stem cells were similar to human embryonic stem cells by the
criteria of morphology, gene expression, DNA methylation,
teratoma formation, and long-term self-renewal ability (Ade-
wumi et al., 2007; Thomson et al., 1998). Chromosomal
structures and genome sequences were maintained during the
induction process, indicating that pluripotent stem cells
generated by this method may have tremendous potential for
therapeutic applications as well as for patient-specific in vitro
models to investigate disease etiology and the role of genetic
variation in response to drugs.
Strong silencing of the four ectopically expressed genes
indicates that these four genes are not necessary for the
maintenance of induced pluripotent stem cells. This is
similar to the situation described for mouse Nanog-iPS cells
(Maherali, 2007; Okita et al., 2007; Wernig et al., 2007). The
difference in the kinetics of pluripotent stem cell induction
after the four-gene transduction between mouse and human
cells could be caused by the slower doubling time and the
slower silencing kinetics of the ectopically expressed genes
in human cells (Koch et al., 2006). The ratios of ES-cell-like
colonies to Nanog-positive colonies in the primary induction
culture were similar for the mouse and human systems
(Wernig et al., 2007). The efficiency of establishing human
induced pluripotent stem cells was more than 1 order of
magnitude lower than that for mouse induced pluripotent
stem cells in our experiments.Figure 5 Pluripotency of the human iPS cell clone 1–8. Cells of huma
56 days after injection. (A) HE and Alcian blue staining of formalde
representative of the three germ layers. Ne, neural epithelium; ca, c
transplant were distinguished from host tissues by HuNu staining.
chondrocytes (C), and α-fetoprotein-expressing endodermal tract (D)Although Nanog gene expression is an important marker for
the induction of mouse iPS cells (Okita et al., 2007; Wernig
et al., 2007), we identified a marked heterogeneity in Nanog-
positive colonies generated by the four-gene transduction
method in human neonatal skin-derived cells. Archetypal
pluripotent stem cell marker genes such as Nanog, TDGF1, and
Dnmt3b showed a higher probability of being induced by the
four-gene transduction compared tomarker genes that are less
specific for pluripotent stem cells (CYP26A1 and TERT)
(Adewumi et al., 2007; Assou et al., 2007). This tendency
might suggests that factors that activate gene expression of
marker genes that are less specific for pluripotent stem cells
may stimulate the induction of human iPS cells. On the other
hand, it is well known that skin-derived cells contain multiple
somatic stem cells, progenitor cells, and somatic cells
(Blanpain and Fuchs, 2006; Sorrell and Caplan, 2004). Thus
heterogeneity of cells in the tissue may contribute to the
heterogeneity of colonies in primary induction culture andmayn iPS clone 1–8 were injected into SCIDmouse testis and analyzed
hyde-fixed teratoma sections. The teratomas contained tissues
artilage; et, endodermal tract. (B–D) Tissues originating from the
Nestin-expressing neural epithelium (B), collagen II-expressing
are shown.
113Heterogeneity of pluripotent marker gene expression in colonies generated in human iPS cell induction cultureinfluence the efficiency of pluripotent stem cell induction. In
addition, culture conditions during in vitro propagation of the
cell sources of human iPS cells may contribute to the
heterogeneity of colonies in the primary induction culture by
altering the epigenetic state of the parent cells.
If epigenetic reprogramming is involved in the process of
human iPS cell induction, DNA demethylation should play an
important role in this process. Although the mechanism of
DNA demethylation remains unclear and controversial, four
classes of mechanism have been proposed: removal of the
methyl moiety from the base, excision of the methylated
base, excision of the methylated nucleotide, or cleavage of
the DNA backbone at the 3′ site of methylcytidine followed
by the DNA repair process (Kress et al., 2001, 2006). In ad-
dition, failure to methylate following DNA replication may be
a possible mechanism underlying promoter activation of the
pluripotency genes. Our genome-wide SNP analysis indicated
no marked differences between human iPS cells and the
parental cells. In addition, it is important to consider the
possibility that rare naïve adult progenitor cells present in
the somatic tissue with a similar DNAmethylation state to iPS
cells serve as the source of iPS cells. Further studies are
necessary to identify the molecular mechanisms underlying
induction of pluripotency in the parental cells.
Methods
Viral infection and induction of human neonatal
skin-derived cells
Adenovirus vector plasmids for mCAT1 were transfected into
HEK293 cells. The mCAT1 adenoviruses were isolated from
these cells by three freeze–thaw cycles, purified using an
adenovirus purification kit (Clontech), and stored at −80 °C.
The titer of the vector stockswas determined using anAdeno-X
rapid titer kit (Clontech).
The replication-deficient MMLV-derived retrovirus vector
pMX (Kitamura et al., 2003) was used for the ectopic
expression of human Oct3/4, Sox2, c-Myc, and Klf4. Recombi-
nant retroviruses were generated by transfecting vectors to
the Plat-E packaging system (Morita et al., 2000) followed by
incubation in FBM (Lonza) supplemented with FGM-2 Single-
Quots (Lonza). Between 24 and 48 h after the transfection,
supernatant from the Plat-E culture was collected several
times at intervals of at least 4 h and passed through a 0.45-μm
filter.
For MEF-conditioned medium (MEF-CM) preparation,
human ES medium (DMEM/F12; Gibco) supplemented with 20%
Knockout Serum Replacement (Invitrogen), 2 mM L-glutamine
(Sigma), 1×nonessential amino acids (Sigma), 10 μg/ml genta-
mycin (Gibco), and 10 ng/ml bFGF (Peprotech) was condi-
tioned on mitomycin C-treated MEFs (Reprocell) for 20–24 h,
harvested, filtered through a 0.45-μm filter, and supplemented
with 0.1 mM 2-mercaptoethanol (Sigma) and 10 ng/ml bFGF
before use.
Fibroblasts were obtained from human neonatal foreskin,
by biopsy under informed consent (Lonza, followed by
culture in FBM supplemented with FGM-2 SingleQuots. Cells
derived from five different donors were used in this study
(5F0416, 5F0438, 5F0439, 5F0474, 5F1195). Three days
before the four-gene introduction, cells were seeded at103–104 cells/cm2 into six-well plates. Ten to 18 h later, the
cells were mixed with the mCAT1 adenovirus vector solution
in 500 μl Hanks’ balanced salt solution and incubated at room
temperature for 30 min. The cells were then added to 2 ml of
medium and cultured for 48 h. Subsequently, the cells were
incubated in 2 ml of the retrovirus/Polybrene solution
(mixture of equal volumes of the retrovirus vector suspension
for each of the four genes, supplemented with 5 μg/ml
Polybrene) at 37 °C for 4 h to overnight. The medium was
changed from retrovirus/Polybrene solution to MEF-CM imme-
diately after the infection. Medium was changed every 1–
2 days.
Cell maintenance of human induced pluripotent
stem cell lines
Clone isolation experiments and colony analyses were per-
formed as separate experiments. Colony analyses (shown in
Fig. 1) were performed using two different donor cell lots:
5F0416 and 5F0474. Colonies induced by the ectopic expres-
sion of four genes were isolated on day 17 to 33 after the four-
gene transduction by using a cloning cylinder or forceps.
Human iPS clones 1–8 and 3–2 were established from human
neonatal dermal cells of Lot 5F0438 and human iPS clone 2–4
was established from human neonatal dermal cells of Lot
5F0416. Human induced pluripotent stem cell lines were estab-
lished by repeated cloning on a feeder layer of MEFs in human
ES medium supplemented with 0.1 mM 2-mercaptoethanol and
10 ng/ml bFGF or on Matrigel (BD; #354230 or #354277) -coated
plates in mTeSR1 medium (Stem Cell Technologies).
For passaging, cells were usually treated with the ROCK
inhibitor Y-27632 (Calbiochem) as previously described, to
prevent apoptosis. Cells were washed with Hanks’ balanced
salt solution, incubated in 0.25% trypsin–EDTA (Gibco) at 37 °C
for 3 min, and then added to the culture medium. Cells were
centrifuged at 300g at 4 °C and the supernatant was removed.
The cells were resuspended in culture mediumwith 5 to 20 μM
Y-27632. The passages were split at 1:4 to 1:6.
Human induced pluripotent stem cell lines were frozen
using Cell Freezing Solution for ES cells (Reprocell) according
to the manufacturer’s manual.
Alkaline phosphatase staining
Cells were fixed with 10% neutral-buffered formalin solution
(Wako) at room temperature for 5 min, washed with PBS, and
incubated with alkaline phosphatase substrate (One-Step
NBT/BCIP; Pierce) at room temperature for 20–30 min.
Cells positive for alkaline phosphatase activity were stained
blue-violet.
Real-time PCR gene expression analyses
For the quantitative analysis of gene expression in colonies
generated in primary induction culture, total RNA was ex-
tracted from fixed colonies using the RecoverAll Total Nucleic
Acid Isolation kit (Ambion). After cDNA preparation, genes of
interest were amplified using TaqMan preamp (Applied
Biosystems). Real-time quantitative PCR was performed
with an ABI Prism 7900HT (Applied Biosystems) using the
following PCR primer sets (Applied Biosystems) Nanog,
114 H. Masaki et al.Hs02387400_g1; TERT, Hs00162669_m1; GDF3,
Hs00220998_m1; CYP26A1, Hs00175627_m1; GAPDH,
Hs99999905_m1; Dnmt3b, Hs00171876_ml; FoxD3,
Hs00255287_s1; Zfp42, Hs01938187_s1; and TDGF1,
Hs02339499_g1. Standard curves were generated for
each primer pair. All expression values were normalized to
GAPDH.
Teratoma formation
iPS cell suspension (0.5 to 2×106 cells/mouse) was injected
into the medulla of the left testis of 7-to 8-week-old SCID
mice (CB17; Oriental Yeast) using a Hamilton syringe. After 6
to 8 weeks, the teratomas were excised after perfusion with
PBS followed by 10% buffered formalin and subjected to
histological analysis.
Histology and immunohistochemistry
Teratomas were embedded in mounting medium, and 10 μm
frozen sections were prepared. Serial sections were
stained with hematoxylin–eosin (HE) to visualize the gen-
eral morphology. For the detection of cartilage, Alcian
blue staining was employed alone or in combination with
HE.
For immunostaining, sections were treated with Immuno-
block (Dainippon–Sumitomo) for 30 min to block nonspecific
binding. Slides were incubated with the following primary
antibodies: anti-nestin polyclonal antibody (PRB-570C,
Covance, 1:300), anti-type II collagen polyclonal antibody
(LB-1297, LSL, 1:200), anti-smooth muscle actin polyclonal
antibody (RB-9010-R7, Lab Vision, 1:1), anti-α-fetoprotein
polyclonal antibody (A0008, Dako, 1:500), anti-MUC-1
polyclonal antibody (RB-9222-P0, Lab Vision, 1:100), and
anti-human nuclei monoclonal antibody (HuNu) (MAB1281,
Chemicon, 1:300). For type II collagen, the sections were
incubated with hyaluronidase (25 mg/ml) for 30 min before
the treatment with primary antibodies. Localization of
antigens was visualized by using appropriate secondary
antibodies (Alexa Fluor 594 and 688, Molecular Probes,
1:600). Nuclei were stained with DAPI (InnoGenex). Immu-
nostained teratoma sections were analyzed by fluorescence
microscopy (Axio Imager Z1, Zeiss).
Karyotype analysis
Karyotype analysis of long-term cultured human iPS cells was
performed using multicolor FISH analysis. Human iPS clone
1–8-derived cells were pretreated with 0.02 μg/ml colece-
mid (Nacalai) for 2–3 h, incubated with 0.06–0.075 M KCl for
20 min, and then fixed with Carnoy’s fixative. For multicolor
FISH analysis, cells were hybridized with the multicolor FISH
probe (Cambio) and analyzed using a DMRA2 fluorescence
microscope (Leica).
DNA microarray analysis
The microarray study was carried out using Human Genome
U133 Plus 2.0 gene expression arrays (Affymetrix) and Whole
Human Genome Oligo microarrays (Agilent). Detailed meth-
ods are available in the Supplementary Information.Methylation analysis
The promoter regions of Nanog and Oct3/4 were analyzed for
methylation of individual CpG sites. Tennanograms of bisulfite-
treated genomic DNAwas PCR-amplified with primers contain-
ing a T7 promoter (Supplementary Table 5), and transcripts
were treated with RNase A. Methylation of individual CpG sites
was assessed using a MALDI-TOF mass spectrometry-based
method (Ehrich et al., 2005) (Epityper, Sequenom). Mass spec-
tra were collected using a MassARRAY mass spectrometer
(Bruker Sequenom). Spectra were analyzed using proprietary
peak picking and signal-to-noise calculations.
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